Guided care to start cancer treatment on time after surgery
Part of Cancer, Ear, nose & throat, Lungs & breathing, Mouth & dental clinical trials.
This trial tests a navigation program (help from a care coordinator) versus usual care to help people start the recommended “next-step” treatments (like radiation, sometimes with chemo) on time after surgery. It’s for certain stages of squamous cell cancer in the head and neck area where late treatment could matter.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have squamous cell cancer in the mouth, throat (oropharynx/hypopharynx/larynx), sinuses, nasal cavity, or an unknown primary site.
- Your cancer stage (based on exams/scans) is more advanced: T3–T4 and/or N1 or higher.
- You have not had radiation therapy for head-and-neck squamous cell cancer before (in the main treatment or after treatment).
- You plan curative-intent surgery at one of the participating study centers.
- After surgery, you’re expected to need post-surgery treatment (usually radiation, with or without chemo) because your final pathology may show higher-risk features like T3–T4, N1+ nodes, nerve invasion, or blood/lymph vessel invasion.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two drugs—an immunotherapy (PD-1 inhibitor) and a targeted therapy (cetuximab)—given before surgery to shrink advanced head and neck cancers. The goal is to see if this approach can lower the risk of the cancer coming back.
This trial tests whether patients with early-stage oral cancer who have surgery and lymph-node removal can skip radiation to the neck if certain favorable conditions are met. The goal is to reduce side effects like difficulty swallowing while keeping cancer control strong.
This Phase 2 study tests whether changing the “radiation volume” (how much area is treated) can better preserve swallowing after surgery for oral cavity squamous cell cancer. It may help reduce swallowing problems while still treating the cancer safely.
This Phase 2 trial tests a specific, shorter type of focused radiation to help relieve symptoms from head and neck squamous cell carcinoma. It compares two radiation timing/planning approaches to see which better improves comfort and quality of life.
This trial tests a new program to help people who finished treatment for head and neck cancer stay on track with follow-up care. You may be able to join if you completed treatment 3 to 6 months ago and your cancer has not spread.
This trial tries a more personalized treatment approach for people with locally advanced head and neck cancers by testing their tumor and blood for cancer “genetic” clues. If you may be eligible, you would have fresh tumor (and possibly lymph node) biopsies at the start and again if the cancer returns, plus blood tests to guide research and future study options.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.